Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hemp Supplement Sales Continue In US Without FDA Acknowledgement As Lawful Products

Jan 26 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Measuring Consumer Exposure Confounds US FDA’s Evaluation Of Cannabinoid Safety In Supplements

Sep 10 2021

First US Warnings On Drug Claims By Delta-8 THC Supplements Also Describe Safety Concerns

May 05 2022

FDA Opens CBD Regulatory Path Docket, Warns Firms On Claims Missteps

Apr 03 2019

Additional Topics

International United States US States Cannabidiol CBD FDA Legislation Business Strategies Commercial Compliance Consumer Dietary Supplements Enforcement Ingredients Manufacturing Lobbying OTC Drugs Policy Politics Regulation Retail Safety Supply Chain

More from Cannabis/CBD

More from Ingredients & Safety

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window